Skip to main content
. 2006 Dec;3(12):50–59.

Table 5.

Treatment emergent adverse events occurring in ≥2% of subjects treated with alprazolam ODT in combination with an SSRI or SNRI or an SSRI/SNRI alone

SSRI/SNRI plus alprazolam ODT N=71 SSRI/SNRI alone N=71
n % n %
Fatigue 5 7.0% 1 1.4%
Headache 4 5.6% 4 5.6%
Nausea 3 4.2% 2 2.8%
Somnolence 3 4.2% 0 0
Dry Mouth 3 4.2% 0 0
Constipation 2 2.8% 2 2.8%
Diarrhea 2 2.8% 1 1.4%
Dizziness 2 2.8% 1 1.4%
Dysgeusia 2 2.8% 0 0